 Opiant Pharmaceuticals, Inc. NASDAQ:OPNT Q1 2022 Results Conference Call May 10, 2022 4:30 PM ET Company Participants Ben Atkins - Vice President, Communications and Investor Relations Dr. Roger Crystal - Chief Executive Officer Dr. Phil Skolnick - Chief Scientific Officer David OToole - Chief Financial Officer Matt Ruth - Chief Commercial Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Leland LelGershell - Oppenheimer David Bautz - Zacks Operator Greetings, and welcome to Opiant Pharmaceuticals First Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. 